[go: up one dir, main page]

GB2358400B - Method of generating mutant C. elegans exhibiting increased compound uptake - Google Patents

Method of generating mutant C. elegans exhibiting increased compound uptake

Info

Publication number
GB2358400B
GB2358400B GB0109263A GB0109263A GB2358400B GB 2358400 B GB2358400 B GB 2358400B GB 0109263 A GB0109263 A GB 0109263A GB 0109263 A GB0109263 A GB 0109263A GB 2358400 B GB2358400 B GB 2358400B
Authority
GB
United Kingdom
Prior art keywords
exhibiting increased
generating mutant
increased compound
compound uptake
elegans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0109263A
Other versions
GB0109263D0 (en
GB2358400A (en
Inventor
Philippe Verwaerde
Richard Feichtinger
Myriam Beghyn
Thierry Bogaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9908677.9A external-priority patent/GB9908677D0/en
Application filed by Devgen NV filed Critical Devgen NV
Priority to GB0109263A priority Critical patent/GB2358400B/en
Publication of GB0109263D0 publication Critical patent/GB0109263D0/en
Publication of GB2358400A publication Critical patent/GB2358400A/en
Application granted granted Critical
Publication of GB2358400B publication Critical patent/GB2358400B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/60—New or modified breeds of invertebrates
    • A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G01N2333/43534—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB0109263A 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake Expired - Fee Related GB2358400B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0109263A GB2358400B (en) 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9908677.9A GB9908677D0 (en) 1999-04-15 1999-04-15 Compound assay
GB0109263A GB2358400B (en) 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake
GB0009360A GB2351152B (en) 1999-04-15 2000-04-14 Screen for pharmacological activity using nematode worms

Publications (3)

Publication Number Publication Date
GB0109263D0 GB0109263D0 (en) 2001-05-30
GB2358400A GB2358400A (en) 2001-07-25
GB2358400B true GB2358400B (en) 2002-01-16

Family

ID=26244117

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0109262A Expired - Fee Related GB2358399B (en) 1999-04-15 2000-04-14 Method of identifying mutant or transgenic nematodes exhibiting increased compound uptake
GB0109263A Expired - Fee Related GB2358400B (en) 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0109262A Expired - Fee Related GB2358399B (en) 1999-04-15 2000-04-14 Method of identifying mutant or transgenic nematodes exhibiting increased compound uptake

Country Status (1)

Country Link
GB (2) GB2358399B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054815A2 (en) * 1999-03-16 2000-09-21 Devgen Nv Expression of dna or proteins in c. elegans

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054815A2 (en) * 1999-03-16 2000-09-21 Devgen Nv Expression of dna or proteins in c. elegans

Also Published As

Publication number Publication date
GB0109263D0 (en) 2001-05-30
GB2358400A (en) 2001-07-25
GB2358399A (en) 2001-07-25
GB0109262D0 (en) 2001-05-30
GB2358399B (en) 2002-01-16

Similar Documents

Publication Publication Date Title
EP1382135A4 (en) Interference suppression methods for 802.11
EG24968A (en) Prodrugs of 4-phenyl-pyridine derivatives.
GB0028264D0 (en) Well treatment
MXPA01003642A (en) ENZYMATIC SYNTHESIS OF ssDNA.
MXPA03001001A (en) Anticonvulsant derivatives useful for the treatment of depression.
AU2002215125A1 (en) Well treatment method
GB2350852B (en) Well operating method
ZA200108446B (en) Novel method of treatment.
MXPA03001800A (en) Process for the preparation of substituted phenylacetonitriles.
GB2366639B (en) Method of comparing parts
ZA200110388B (en) Method of producing nitroguanidine- and nitroenamine derivatives.
IL144024A0 (en) Reactor for generating moisture
ZA200210361B (en) Method of administering bishosphonates.
GB2358400B (en) Method of generating mutant C. elegans exhibiting increased compound uptake
ZA200101529B (en) Process for the preparation of isoindoline.
SG102028A1 (en) Reactor for generating moisture
MXPA03005933A (en) Process for the manufacture of solid formulations.
AP2005003432A0 (en) Novel method of treatment.
PL347407A1 (en) Method of obtaining derivatives of 5,6,7,8-tetrahydronaphtalen-2-ole
AUPQ790900A0 (en) Treatment for scrubber effulent
PL342955A1 (en) Method of obtaining 1,4:3,6-dianhydro-d,l-iditole from galactitole
GB0113781D0 (en) Compound
AU2001230250A1 (en) Method for synthesizing 2,2,4,4-tetrasubstituted 1,3,5-cyclohexane trions
PL331787A3 (en) Method of obtaining 2,3-dibromo-2-butene-1,4-diole
AUPR221100A0 (en) Method of generating targeted ligands

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20090414